Skip to main content
CA.Gov State of California Logo
en Español Contact Us About News & Media Jobs/Careers
+ Increase Text Resize Reset to Default - Decrease
CDPH Site Logo
CDPH Site Logo
  • Text Size
      • + Increase Increase
      • - DecreaseDecrease
      • Reset to Default Reset to Default
  • I am looking for
      • What’s New

      • 2025 State of Public Health Testimony

      • CDPH New Look

      • H5N1 Bird Flu

      • COVID-19 Dashboard

      • Tips for After an Earthquake

      • Wildfire Preparedness and Safety

      • CDPH 2025-26 Budget May Revision

      • Public Health for All

      • Administrative

      • All Local Health Jurisdiction Letters & Notices

      • Budget Highlights

      • Boards and Advisory Committees

      • Forms

      • Language Access Services Program

      • Local Health Services/Offices

      • Public Records Act Request

      • Proposed Regulations

      • Proposition 56 Fiscal Reporting

      • Diseases and Conditions

      • Cancer

      • COVID-19

      • Diabetes

      • Diseases and Conditions

      • Disease Reporting

      • Healthcare-Associated Infections

      • HIV/AIDS

      • Mpox

      • Problem Gambling

      • Respiratory Viruses

      • Sexually Transmitted Diseases

      • See More
      • Family Health

      • Breastfeeding

      • Genetic Disease Screening

      • Mental Health

      • Nutrition and Physical Activity

      • Pregnancy and Reproductive Health

      • Women, Infants and Children

      • Health and Safety

      • Climate Change and Health

      • Emergency Preparedness

      • Environmental Health

      • Health in all Policies

      • Workplace Health

      • Health Facilities

      • File a Complaint

      • California Health Facilities Information Database

      • Personal Health and Prevention

      • Behavioral Health

      • Cannabis (Marijuana)

      • Immunizations

      • Nutrition

      • Quit Smoking

      • Licensing, Certification and Other Credentials

      • Certificates, Licenses, Permits and Registrations

      • Health Care Facility Licenses

      • Health Care Professionals

      • Laboratory

      • Medical Professional Licenses

      • Medical Waste

      • Pet Importation and Exportation

      • Radiation and Nuclear

      • Registered Environmental Health Specialist

      • Vital Records

      • X-ray Machine Registration

  • I am a
      • Clinician / Healthcare Provider

      • Legislator / Legislative Staff

      • Media Representative

      • Researcher / Statistician

      • Person Interested In

      • Infant and Child Health

      • Men’s Health

      • Senior Health

      • Women’s Health

      • Youth and Young Adult's Health

      • LGBT Health

  • Programs
      • Center for Healthy Communities

      • California Tobacco Control

      • Childhood Lead Poisoning Prevention

      • Chronic Disease Control

      • Chronic Disease Surveillance and Research

      • Emergency Preparedness

      • See More
      • Center for Preparedness and Response

      • Be Prepared California

      • Know and Understand Natural Disasters

      • Center for Family Health

      • Genetic Disease Screening Program

      • Maternal, Child and Adolescent Health

      • Women, Infants and Children

      • Center for Health Care Quality

      • Healthcare-Associated Infections Program

      • Licensing and Certification

      • Center for Health Statistics and Informatics

      • End of Life Option Act

      • Medical Marijuana Identification Card Program

      • Research and Analytics Branch

      • Vital Records

      • Center for Infectious Diseases

      • HIV/AIDS

      • Binational Border Health

      • Communicable Disease Control

      • Communicable Disease Emergency Response

      • Refugee Health

      • See More
      • Director / State Public Health Officer

      • Legislative and Governmental Affairs

      • Let's Talk Cannabis

      • Office of Health Equity

      • Office of Communications

      • See More
      • Center for Environmental Health

      • Division of Food and Drug Safety

      • Division of Radiation Safety and Environmental Management

      • See More
      • Center for Laboratory Sciences

      • Division of Environmental Health Laboratories

      • Infectious Diseases Laboratory Division

      • Laboratory Field Services

      • Office of State Public Health Laboratory Director

      • Operations Branch

      • See More
      • Other CDPH Offices

      • Privacy Office

      • Office of Regulations

      • See More
  • A-Z Index
California Safe Cosmetics

Skip Navigation LinksReportingGuidance
 

Top Menu
  • Occupational Health BranchCurrently selected
    • About Occupational Health Branch
    • Occupational Health Branch Programs and Activities
    • Occupational Health Branch Publications & Videos
    • Data & Statistics
    • Contact OHB
    • What's New at the Occupational Health Branch
    • Newsletter
    • Work-Related Valley Fever (Coccidioidomycosis)
    • Occupational Health Watch February 2017
    • Occupational Health Watch March 2017
    • Occupational Health Watch January 2017
    • Occupational Health Watch April 2017: Spotlight on Skylight Falls for Workers Memorial Day
    • Occupational Health Watch November 2016
    • Occupational Health Watch October 2016
    • Occupational Health Watch September 2016
    • Occupational Health Watch July 2016: August Is Valley Fever Awareness Month
    • Occupational Health Watch June 2016
    • Occupational Health Watch May 2016
Skip Navigation LinksOccupational Health Branch > California Safe Cosmetics > Pages > ReportingGuidance
  • Home
  • Programs
  • Center for Healthy Communities
  • Division of Environmental and Occupational Disease Control
  • Occupational Health Branch
  • California Safe Cosmetics
  • Reporting Guidance for Certain Ingredient Types
Left Menu
  • Recent
  • About Occupational Health Branch
  • Occupational Health Branch Programs and Activities
  • Occupational Health Branch Publications & Videos
  • Data & Statistics
  • Contact OHB
  • What's New at the Occupational Health Branch
  • Newsletter
  • Work-Related Valley Fever (Coccidioidomycosis)
  • Occupational Health Watch February 2017
  • Occupational Health Watch March 2017
  • Occupational Health Watch January 2017
  • Occupational Health Watch April 2017: Spotlight on Skylight Falls for Workers Memorial Day
  • Occupational Health Watch November 2016
  • Occupational Health Watch October 2016
  • Occupational Health Watch September 2016
  • Occupational Health Watch July 2016: August Is Valley Fever Awareness Month
  • Occupational Health Watch June 2016
  • Occupational Health Watch May 2016
  • California Safe Cosmetics
    • About CSCP
    • Cosmetics Resources
    • Publications
    • Cosmetics Companies
    • CSCP Online Reporting System FAQs
    • Contact CSCP
    • SB312
    • Reporting Checklist
    • Who Needs To Submit
    • How to Create an Account
    • How to Submit a Product
    • How To Search the CSCP Product Database
    • CAPABLE Study
    • Reporting Guidance for Certain Ingredient TypesCurrently selected
    • Compliance Info & FAQ
    • Fragrance Allergens

California safe cosmetics program

  • CSCP Home
  • About CSCP
  • Contact CSCP
  • Subscribe to CSCP Updates
  • +Publications & Resources
    • Resources
    • Program Publications
    • CSCP Online Reporting System
    • Cosmetics Product Database
  • For Cosmetics Companies
  • Occupational Health Branch (OHB)
  • +Workplace Health & Safety Resources
    • General health and safety links
    • For workers
    • En español
    • For employers
    • For health care providers

Different Types of Ingredients and When They Must Be Reported

The California Safe Cosmetics Act of 2005 (CSCA) and the Cosmetics Fragrance & Flavor Ingredient Right to Know Act of 2020 (CFFIRKA) both require companies to report products containing specific hazardous ingredients to the California Department of Public Health (CDPH). CSCP has compiled those ingredients into the Reportable Ingredient List (Excel). The following definitions and guidance are intended to help companies understand how to report some products and ingredient types that may require clarification. More information about these laws is available on the CSCA and CFFIRKA Compliance Information page.

  • Ingredient
  • Fragrance Ingredient
  • Flavor Ingredient
  • Fragrance Allergen
  • Naturally Occurring Chemicals
  • Incidental Ingredient
  • Cosmetic-Drugs or Over-the-Counter (OTC) Drugs
  • Titanium Dioxide
  • Carbon Black and Carbon Black Extracts
  • Crystalline Silica
  • Aloe Vera

Ingredient1 is defined as any single chemical entity or mixture used as a component in the manufacture of a cosmetic product. There is an exception in the law for incidental ingredients—see definition below.

Fragrance ingredient2 is any intentionally added substance or complex mixture of aroma chemicals, natural essential oils, and other functional ingredient or ingredients for which the purpose is to impart an odor or scent, or to counteract an odor.

Flavor ingredient2 is any intentionally added substance or complex mixture of aroma chemicals, flavor chemicals, natural essential oils, and other functional ingredient or ingredients for which the purpose is to impart a flavor or taste, or to counteract a flavor or taste.

Fragrance allergens are reportable under CFFIRKA, but unlike fragrance ingredients defined above, they must be reported regardless of their intended purpose in the product, i.e. they must be reported even if they are not used to impart scent or counteract odor. Fragrance allergens must be reported when present in a rinse-off cosmetic product at a concentration at or above 0.01 percent (100 parts per million) or in a leave-on cosmetic product at a concentration at or above 0.001 percent (10 parts per million). 

Please note, as of March 27, 2024, the Reportable Ingredient List's Summary of Updates tab has an asterisk added next to each of the European Union's (EU) newly listed fragrance allergens. The following information applies to the ingredients with the asterisk: A manufacturer of a cosmetic product sold in the state shall report a list of each fragrance allergen included in Annex III of the EU Cosmetics Regulation No. 1223/2009, as required to be reported pursuant to the EU Detergents Regulation No. 21 648/2004. Manufacturers must report listed allergens to the California Department of Public Health no later than the timelines required under the EU law, i.e., 2026 or 2028; however, manufacturers may report at any time prior to the deadlines.

Naturally occurring chemicals that are constituents of an intentionally added ingredient must be reported if they are on the Reportable Ingredients List. For example, beta-myrcene is in some essential oils and must be reported if so.

Incidental ingredients3 do not need to be reported if they are present in a cosmetic at insignificant levels or trace amounts. Incidental ingredients are:

  • Substances that have no technical or functional effect in the cosmetic but are present by reason of having been incorporated into the cosmetic as an ingredient of another cosmetic ingredient.
  • Processing aids, which are as follows:
    • Substances that are added to a cosmetic during the processing of such cosmetic but are removed from the cosmetic in accordance with good manufacturing practices before it is packaged in its finished form.
    • Substances that are added to a cosmetic during processing for their technical or functional effect in the processing, are converted to substances the same as constituents of declared ingredients, and do not significantly increase the concentration of those constituents.
    • Substances that are added to a cosmetic during the processing of such cosmetic for their technical and functional effect in the processing but are present in the finished cosmetic at insignificant levels and do not have any technical or functional effect in that cosmetic.

Cosmetic Drugs or Over-the-Counter (OTC) Drugs: According to the U.S. Food and Drug Administration, some products meet the definitions of both cosmetics and drugs under federal law (the Federal Food, Drug and Cosmetic Act). CSCA and CFFIRKA apply to any cosmetic product subject to regulation by the federal Food and Drug Administration.4 Examples of products that meet both definitions and must be reported are:

  • Lip balms that moisturize or have a color tint
  • Anti-dandruff shampoos
  • Antiperspirants with deodorant

Titanium dioxide is reportable due to its listing by IARC5 as a possible human carcinogen. The IARC listing is based on sufficient evidence of carcinogenicity in experimental animal studies, i.e., evidence that animals exposed to airborne respirable particles of titanium dioxide developed lung cancer. Titanium dioxide is also listed under Prop 656 as “titanium dioxide (airborne, unbound particles of respirable size).” Companies need only report products with titanium dioxide that can potentially be present as airborne, unbound particles of respirable size, including products that are in powder form, pressed powders, aerosols, and other products that are inhalable.

Carbon black is reportable due to its listing by IARC7 as a possible human carcinogen. The IARC listing is based on sufficient evidence of carcinogenicity in experimental animal studies, i.e., evidence that animals exposed to airborne respirable particles of carbon black developed lung cancer. Carbon black is also listed under Prop 658 as “Carbon black (airborne, unbound particles of respirable size).” Companies need only report products with carbon black that can potentially be present as airborne, unbound particles of respirable size, including products that are in powder form, pressed powders, aerosols, and other products that are inhalable.  

Carbon black extracts are also reportable due to being listed by IARC as a possible human carcinogen. The IARC listing is based on sufficient evidence of carcinogenicity in experimental animal studies, i.e., evidence that animals dermally or subcutaneously exposed to carbon black extracts developed tumors. Companies must report all products containing carbon black extracts. 

Crystalline silica in the form of quartz, cristobalite, and cristobalite dust is reportable due to its listing by IARC9 as a human carcinogen. The IARC listing for crystalline silica is based on sufficient evidence of carcinogenicity in humans, i.e., crystalline silica causes lung cancer. Crystalline silica is also listed under Prop 6510 as "Silica, crystalline (airborne, unbound particles of respirable size)." Companies need only report products with crystalline silica that can potentially be present as airborne, unbound particles of respirable size, including products that are in powder form, pressed powders, aerosols, and other products that are inhalable.

Whole leaf extract of aloe vera is reportable due to its listing by IARC11 as a possible human carcinogen. Aloe vera is also listed under Prop 6512 as “Aloe Vera, Non-decolorized Whole Leaf Extract.” Decolorized whole leaf extract of aloe vera has been filtered to remove cancer-causing chemicals naturally found in the aloe vera plant. Companies need only report products with non-decolorized (unfiltered) whole extract of aloe vera.


1 Subdivision (e) of Section 700.3 of Part 700 of Chapter 1 of Title 21 of the Code of Federa​l Regulations, as referenced in California Health and Safety Code Section 111791.5, subdivision (d).

2 California Health and Safety Code Section 111792.6. 

3 Subdivision (l) of Section 701.3 of Part 701 of Chapter 1 of Title 21 of the Code of Federal Regulations, as referenced in California Health and Safety Code Section 111791.5, subdivision (d).

4 California Health and Safety Code Section 111792, subdivision (a).

5Carbon Black, Titanium Dioxide, and Talc: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 93.

6Prop 65 listing for titanium dioxide. 

7Carbon Black, Titanium Dioxide, and Talc: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 93.

8Prop 65 listing for carbon black.

9Arsenic, Metals, Fibres, and Dusts: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100C.

10Prop 65 listing for crystalline silica. 

11IARC monograph on aloe vera​.

12Prop 65 list for aloe vera.


Email SafeCosmetics@cdph.ca.gov for more information.

Page Last Updated : March 28, 2024
PHAB
For General Public Information
  • (916) 558-1784
  • Contact Us
  • Web Accessibility Certification
  • Download PDF Viewer
  • Feedback
  • Jobs/Careers
  • Privacy Policy
  • Sitemap
  • Use Policy
Useful Links
  • Visit Governor's Website
  • State Agency Directory
  • CA Health & Human Services
  • Centers for Disease Control and Prevention
Visit CDPH on Instagram for the latest updates and health tips. Follow CDPH on Facebook to stay informed and connected. Explore professional updates and news from CDPH on LinkedIn. Watch health-related videos and get updates from CDPH on YouTube. Stay up to date with tweets and announcements from CDPH on X. Get the latest information and stay informed with CDPH on Bluesky. Connect and engage with CDPH on Threads to get the latest updates. Watch short CDPH videos on TikTok.